David Oh

David Oh has extensive work experience in the pharmaceutical industry. David was an Executive Neuroscience Sales Specialist at ACADIA Pharmaceuticals Inc. from 2016. Prior to that, they worked at Endo Pharmaceuticals / Auxilium as a Specialty Sales Consultant, where they marketed testosterone replacement therapy and helped launch and market Xiaflex for Dupuytren's contracture and Peyronie's disease. David also sold Aveed injectable and Testopel implantable pellets. At Acclarent, they served as a Market Development Specialist, creating marketing initiatives and providing consultative selling to head and neck surgeons. Before that, they were a Biotech Sales Specialist at MedImmune, successfully marketing an injectable monoclonal antibody. David gained expertise in coordinating approval for Synagis. David Oh began their career as a Senior Sales Specialist at GlaxoSmithKline Biologicals, where they achieved high rankings and received awards for their sales performance.

David Oh received a Bachelor of Arts degree in Economics from UC Irvine. The start and end years of their education are not provided.